Proteasome inhibitors can suppress the growth of renal cancer cells by modulating the gene expression of EDEM1, a downstream effector molecule in the unfolded protein response (UPR), through inhibition of GPR78 expression. The gene discussed is GPR78; the disease is renal carcinoma.